Skip to content

Ionis Pharmaceuticals IONS Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$326.98M+28.6%-$381.39M+16.0%-$256.34M+28.6%-$268.22M+26.7%-$458.03M-19.0%
$11.08M+19.2%$10.01M+4.1%$8.99M-9.4%$9.1M-9.8%$9.3M-9.2%
$147.43M+14.7%$133.87M+2.8%$126.7M+5.2%$127.54M+11.5%$128.58M+16.7%
-$910.63M-81.5%-$268.58M+46.4%-$247.01M+46.5%-$230.57M+49.4%-$501.78M-15.8%
$60.63M+13.6%$51.44M+13.6%$55.65M+181%$59.44M+362%$53.36M+186%
$88.59M-$277.78M
$730.9M+45.9%$675.84M+29.4%$84.66M-85.0%$499.49M+647%$500.8M+141%
-$90.81M$130.18M$3.74M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Ionis Pharmaceuticals generate?
Ionis Pharmaceuticals (IONS) generated -$910.6M in operating cash flow over the trailing twelve months.
What is Ionis Pharmaceuticals's free cash flow?
After $60.6M of capital expenditures, Ionis Pharmaceuticals's free cash flow was -$1.3B over the trailing twelve months, down 133.2% year over year.
Where does Ionis Pharmaceuticals's cash flow data come from?
Every line is extracted from Ionis Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.